A clinical study to see the effect of an ayurvedic preparation in management of timira with special reference to myopia

An open labelled randomized placebo controlled clinical study on saptamrita lauha in the management of timira with special reference to myopia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021643

Enrollment

Registered

2019-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H53-H54- Visual disturbances and blindness

Interventions

Intervention1: Saptamrita Lauha: Saptamrita Lauha 500 mg With Milk Twice a Day for 60 Days Control Intervention1: Placebo: Placebo 500 mg Twice a Day for 60 Days

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of Timira (Simple Myopia) described as per Ayurvedic and modern science irrespective of age sex occupation and religion

Exclusion criteria

Exclusion criteria: 1. Patients having a dioptre power more than â??6.00 dioptre (Pathological myopia) will also be excluded 2. Patients having any other ocular pathology, e.g., cataract, corneal opacity, iridocyclitis, retinal disease etc. will be excluded. 3. Patients suffering from systemic diseases will also be excluded.

Design outcomes

Primary

Measure	Time frame
To see the efficacy of Saptamrita Lauha in the management of Timira (Myopia)Timepoint: 60 Days	—

Secondary

Measure	Time frame
Any adverse event reported voluntarily, observed or enquired. Recurrence in sign and symptoms of Timira (Myopia)Timepoint: 60 Days	—

Countries

India

Contacts

Public ContactDr Kapil Mehar

National Institute Of Ayurveda

shalakya007@gmail.com9461065960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026